Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 10, 2012, Pages 2206-2213

  Kalkman, Hans O ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Circadian rhythm; ERK1; SYNGAP1; Timothy syndrome

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROFIBROMIN;

14 3 3 EPSILON GENE; AUTISM; BIPOLAR DISORDER; CACNA1C GENE; DRUG CHOICE; DUSP14 GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3 GENE; MUTATOR GENE; NEUROFIBROMIN GENE; NHE9 GENE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNGAP GENE;

EID: 84867600845     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.07.008     Document Type: Review

References (118)

1. Adams, J.P., Sweatt, J.D., 2002. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annual Review of Pharmacology and Toxicology 42, 135-163.
2. Allik, H., Larsson, J.O., Smedje, H., 2006. Sleep patterns of school-age children with Asperger syndrome or high-functioning autism. Journal of Autism and Developmental Disorders 36, 585-595.
3. Anney, R.J.L., Kenny, E.M., O'Dushlaine, C., Yaspan, B.L., Parkhomenka, E., the Autism Genome Project, Buxbaum, J.D., Sutcliffe, J., Gill, M., Gallagher, L., 2011. Geneontology enrichment in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. European Journal of Human Genetics 19, 1082-1089.
4. Avramopoulos, D., Lasseter, V.K., Fallin, M.D., Wolyniec, P.S., McGrath, J.A., Nestadt, G., Valle, D., Pulver, A.E., 2007. Stage II follow-up on linkage scan for bipolar disorder in the Ashkenazim provides suggestive evidence for chromosome 12p and the GRIN2B gene. Genetics in Medicine 9, 745-751.
5. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, A., Yuzda, E., Rutter, M., 1995. Autism as a strongly genetic disorder: evidence from a British twin study. Psychological Medicine 25, 63-77.
6. Balog, Z., Kiss, I., Keri, S., 2010. CACNA1C risk allele for psychotic disorders is related to the activation of AKT-pathway. The American Journal of Psychiatry 167, 1276-1277.
7. Bandyopadhyay, S., Chiang, C.Y., Srivastava, J., Gersten, M., White, S., Bell, R., Kurschner, C., Martin, C.H., Smoot, M., Sahasrabudhe, S., Barber, D.L., Chanda, S.K., Ideker, T., 2010. A human MAP kinase interactome. Nature Methods 7, 801-805.
8. Barnby, G., Abbott, A., Sykes, N., Morris, A., Weeks, D.E., Mott, R., Lamb, J., Bailey, A.J., Monaco, A.P., IMSGSAC, 2005. Candidate-gene screening and association analysis at the autism-susceptibility locus on Chromosome 16p: evidence of association at GRIN2A and ABAT. American Journal of Human Genetics 76, 950-966.
9. Beglinger, L.J., Smith, T.H., 2001. A review of subtyping in autism and proposed dimensional classification model. Journal of Autism and Developmental Disorders 31, 411-422.
10. Blau, J., 2003. A new role for an old kinase: CK2 and the circadian clock. Nature Neuroscience 6, 208-210.
11. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A., Greenberg, M.E., 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcriptiondependent and -independent mechanisms. Science 286, 1358-1362.
12. Bruno, D.L., Anderlid, B.M., Lindstrand, A., van Ravenswaaij-Arts, C., Ganesamoorthy, D., Lundin, J., Martin, C.L., Douglas, J., Nowak, C., Adam, M.P., et al., 2010. Further molecular and clinical delineation of co-locating 17p13. 3 microdeletions and microduplications that show distinctive phenotypes. Journal of Medical Genetics 47, 299-311.
13. Casamassima, F., Hay, A.C., Benedetti, A., Lattanzi, L., Cassano, G.B., Perlis, R.H., 2010. L-type channels and psychiatric disorders: a brief review. American Journal of Medical Genetics 153B, 1373-1390.
14. Chakrabarti, S., Fombonne, E., 2001. Pervasive developmental disorders in preschool children. Journal of the American Medical Association 285, 3093-3099.
15. Chen, H.J., Rojas-Soto, M., Oguni, A., Kennedy, M.B., 1998. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20, 895-904.
16. Cherlyn, S.Y.T., Woon, P.S., Liu, J.J., Ong, W.Y., Tsai, G.C., Sim, K., 2010. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neuroscience and Biobehavioral Reviews 34, 958-977.
17. Comings, D.E., Wu, S., Chiu, C., Muhleman, D., Sverd, J., 1996. Studies of the c-Harvey-Ras gene in psychiatric disorders. Psychiatry Research 63, 25-32.
18. Cullen, P.J., Lockyer, P.J., 2001. Integration of calcium and Ras signalling. Nature Reviews Molecular Cell Biology 3, 339-348.
19. Dawson, T.M., Ginty, D.D., 2002. CREB family transcription factors inhibit neuronal suicide. Nature Medicine 8, 450-451.
20. Ding, Q., Xia, W., Liu, J.C., Yang, J.Y., Lee, D.F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al., 2005. Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Molecular Cell 19, 159-170.
21. Dolmetsch, R.E., Pajvani, U., Fife, K., Spotts, J.M., Greenberg, M.E., 2001. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294, 333-339.
22. Deisseroth, K., Mermelstein, P.G., Xia, H., Tsien, R.W., 2003. Signaling from synapse to nucleus: the logic behind the mechanisms. Current Opinion in Neurobiology 13, 354-365.
23. Dubois, T., Rommel, C., Howell, S., Steinhussen, U., Soneji, Y., Morrice, N., Moelling, K., Aitken, A., 1997. 14-3-3 is phosphorylated by Casein kinase I on residue 233. Journal of Biological Chemistry 272, 28882-28888.
24. Duman, C.H., Schlesinger, L., Kodama, M., Russell, D.S., Duman, R.S., 2007. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry 61, 661-670.
25. Einat, H., Yuan, P., Gould, T.D., Li, J., Du, J.H., Zhang, L., Manji, H.K., Chen, G., 2003. The role of extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 23, 7311-7316.
26. Engel, S.R., Creson, T.K., Hao, Y., Shen, Y., Maeng, S., Nekrasova, T., Landreth, G.E., Manji, H.K., Chen, G., 2009. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Molecular Psychiatry 14, 448-461.
27. Fasano, S., Brambilla, R., 2011. Ras-RK signaling in behavior: old questions and new perspectives. Frontiers in Behavioral Neuroscience 5, 79.
28. Fernandez, B.A., Roberts, W., Chung, B., Weksberg, R., Meyn, S., Szatmari, P., Joseph-George, A.M., MacKay, S., Whitten, K., Noble, B., et al., 2010. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. Journal of Medical Genetics 47, 195-203.
29. Ferner, R.E., 2010. The neurofibromatoses. Practical Neurology 10, 82-93.
30. Ferreira, M.A.R., O'Donovan, M.C., Meng, Y.A., Jones, I.R., Ruderfer, D.M., Jones, L., Fan, J., Kirov, G., Perlis, R.H., Green, E.K., et al., 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 40, 1056-1058.
31. 2+-permeable AMPA receptors recruited by CaM-kinase I. Journal of Neuroscience 30, 11565-11575.
32. Freitag, C.M., 2007. The genetics of autistic disorders and its clinical relevance: a review of the literature. Molecular Psychiatry 12, 2-22.
33. Ghaziuddin, M., Bolyard, B., Alessi, N., 1994. Autistic disorder in Noonan syndrome. Journal of Intellectual Disability Research 38, 67-72.
34. Gillberg, C., Forsell, C., 1984. Childhood psychosis and neurofibromatosis-more than a coincidence? Journal of Autism and Developmental Disorders 14, 1-8.
35. Gilman, S.R., Iossifov, I., Levy, D., Ronemus, M., Wigler, M., Vitkup, D., 2011. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898-907.
36. Glickman, G., 2010. Circadian rhythms and sleep in children with autism. Neuroscience and Biobehavioral Reviews 34, 755-768.
37. Gould, T.D., Zarate, C.A., Manji, H.K., 2004. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. Journal of Clinical Psychiatry 65, 10-21.
38. Green, E.K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., Gordon-Smith, K., Fraser, C., Forty, L., Russell, E., et al., 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and schizophrenia. Molecular Psychiatry 15, 1016-1022.
39. Guo, X., Hamilton, P.J., Reish, N.J., Sweatt, J.D., Miller, C.A., Rumbaugh, G., 2009. Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of schizophrenia. Neuropsychopharmacology 34, 1659-1672.
40. Hamdan, F.F., Daoud, H., Piton, A., Gauthier, J., Dobrzeniecka, S., Krebs, M.O., Joober, R., Lacaille, J.C., Nadieau, A., Milunsky, J.M., et al., 2011a. De novo SYNGAP1 mutations in syndromic intellectual disability and autism. Biological Psychiatry 69, 898-901.
41. Hamdan, F.F., Gauthier, J., Araki, Y., Lin, D.T., Yoshizawa, Y., Higashi, K., Park, A.R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al., 2011b. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. American Journal of Human Genetics 88, 306-316.
42. Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P., Gould, T.D., Manji, H.K., Chen, G., 2004. Mood stabilizer valproate promotes ERK pathway-dependent neuronal growth and neurogenesis. Journal of Neuroscience 24, 6590-6599.
43. Herault, J., Petit, E., Martineau, J., Perrot, A., Lenoir, P., Cherpi, C., Barthelemy, C., Sauvage, D., Mallet, J., Muh, J.P., Lelord, G., 1995. Autism and genetics: clinical approach and association study with two markers of HRAS gene. American Journal of Medical Genetics 60, 276-281.
44. Horev, G., Ellegood, J., Lerch, J.P., Son, Y.E.E., Muthuswamy, L., Vogel, H., Krieger, A.M., Buja, A., Henkelman, R.M., Wigler, M., Mills, A.A., 2011. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proceedings of the National Academy of Sciences of the United States of America 108, 17076-17081.
45. Hussman, J.P., Chung, R.H., Griswold, A.J., Jaworski, J.M., Salyakina, D., Ma, D., Konidari, I., Whitehead, P.L., Vance, J.M., Martin, E.R., Cuccaro, M.L., Gilbert, J.R., Haines, J.L., Pericak-Vance, M.A., 2011. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Molecular Autism 2, 1.
46. Itokawa, M., Yamada, K., Iwayama-Shigeno, Y., Ishitsuka, Y., Detera-Wadleigh, S., Yoshikawa, T., 2003. Genetic analysis of a functional GRIN2A promotor (GT)n repeat in bipolar disorder pedigrees in humans. Neuroscience Letters 345, 53-56.
47. Jaworski, J., Spangler, S., Seeburg, D.P., Hoogenraad, C.C., Sheng, M., 2005. Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. Journal of Neuroscience 25, 11300-11312.
48. Kaladchbachi, S.A., Doble, B., Anthopoulos, N., Woodgett, J.R., Manoukian, S.A., 2007. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. Journal of Circadian Rhythms 5, 3.
49. Kempton, M.J., Ruberto, G., Vassos, E., Tatarelli, R., Girardi, P., Collier, D., Frangou, S., 2009. Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. The American Journal of Psychiatry 166, 1413-1414.
50. Kim, S.H., Shin, S.Y., Lee, K.Y., Joo, E.J., Song, J.Y., Ahn, Y.M., Lee, Y.H., Kim, Y.S., 2012. The genetic association of DUSP6 with bipolar disorder and its effect on Erk activity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 37, 41-49.
51. King, T.D., Song, L., Jope, R.S., 2006. AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochemical Pharmacology 71, 1637-1647.
52. Klinger, S., Poussin, C., Debril, M.B., Dolci, W., Halban, P.A., Thorens, B., 2008. Increasing GLP-1 induced β-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-α and DUSP14. Diabetes 57, 584-593.
53. Klitten, L.L., Møller, R.S., Nikanorova, M., Silahtaroglu, A., Hjalgrim, H., Tommerup, N., 2011. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 52, e190-e193.
54. 2+ signaling. Current Opinion in Neurobiology 17, 112-119.
55. Mathew, S.J., Manji, H.K., Charney, D.S., 2008. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 33, 2080-2092.
56. Komiyama, N., Watabe, A.M., Carlisle, H.J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D.J.C., O'Carroll, C.M., Martin, S.J., Morris, R.G.M., O'Dell, T.J., Grant, S.G.N., 2002. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. Journal of Neuroscience 22, 9721-9732.
57. Kumar, V., Zhang, M.X., Swank, M.W., Kunz, J., Wu, G.Y., 2005. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. Journal of Neuroscience 25, 11288-11299.
58. Kumar, R.A., KaraMohamed, S., Sudi, J., Conrad, D.F., Brune, C., Badner, J.A., Gilliam, T.C., Nowak, N.J., Cook Jr., E.H., Dobyns, W.B., Christian, S.L., 2008. Recurrent 16p11. 2 microdeletions in autism. Human Molecular Genetics 17, 628-638.
59. LeBlanc, J.J., Fagiolini, M., 2011. Autism: a critical period disorder? Neural Plasticity 2011, article ID 921680.
60. Lee, B., Butcher, G.Q., Hoyt, K.R., Impey, S., Obrietan, K., 2005. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinasecoupling, stimulus intensity, and temporal regulation of CREB phosphorylation at Serine 133. Journal of Neuroscience 25, 1137-1148.
61. Lenz, G., Avruch, J., 2005. Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. Journal of Biological Chemistry 280, 38121-38124.
62. Lisman, J., Yasuda, R., Raghavachari, S., 2012. Mechanisms of CaMKII action in longterm potentiation. Nature Reviews Neuroscience 13, 169-182.
63. Looby, P., Loudon, A.S.I., 2005. Gene duplication and complex circadian clocks in mammals. Trends in Genetics 21, 46-53.
64. Luk, S.C., Ngai, S.M., Tsui, S.K., Fung, K.P., Lee, C.Y., Wayne, M.M., 1999. In vivo and in vitro association of 14-3-3 epsilon isoform with calmodulin: implication for signal transduction and cell proliferation. Journal of Cellular Biochemistry 73, 31-35.
65. Malhotra, D., McCarthy, S., Michaelson, J.J., Vacic, V., Burdick, K.E., Yoon, S., Cichon, S., Corvin, A., Gary, S., Gershon, E.S., Gill, M., et al., 2011. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72, 951-963.
66. Marchi, M., D'Antoni, A., Formentini, I., Parra, R., Brambilla, R., Ratto, G.M., Costa, M., 2008. The N-terminal domain of ERK1 accounts for the functional difference with ERK2. PLoS ONE 2, e3873.
67. Marks, M.L., Whisler, S.L., Clericuzio, C., Keating, M., 1995. A new form of long QT syndrome associated with syndactyly. Journal of the American College of Cardiology 25, 59-64.
68. Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al., 2008. Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics 82, 477-488.
69. Martucci, L., Wong, A.H., De Luca, V., Likhodi, O., Wong, G.W., King, N., Kennedy, J.L., 2006. N-methyl-d-aspartate receptor NR2B subunit gene in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophrenia Research 84, 214-221.
70. Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D.P., Pages, G., Valverde, O., Marowsky, A., Porrazzo, A., et al., 2002. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34, 807-820.
71. Mbarek, O., Marouillat, S., Martineau, J., Barthelemy, C., Muh, J.P., Andres, C., 1999. Association study of the NF1 gene and autistic disorder. American Journal of Medical Genetics 88, 729-732.
72. McCarthy, S.E., Makarov, V., Kirov, G., Addington, A.M., McClellan, J., Yoon, S., Perkins, D.O., Dickel, D.E., Kusenda, M., Krastoshevsky, O., et al., 2009. Microduplications of 16p11.2 are associated with schizophrenia. Nature Genetics 41, 1223-1227.
73. McClung, C.A., 2007. Circadian genes, rhythms and the biology of mood disorders. Pharmacology & Therapeutics 114, 222-232.
74. Middleton, F.A., Pato, C.N., Gentile, K.L., McGann, L., Brown, A.M., Trauzzi, M., Diab, H., Morley, C.P., Medeiros, H., Macedo, A., et al., 2005. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. American Journal of Medical Genetics 136B, 12-25.
75. Moore, S.J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D.J., Montgomery, T., Dean, J.C.S., 2000. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 37, 489-497.
76. Moreno-De-Luca, D., consortium, SGENE., Mulle, J.G., Simons Simplex Collection Genetics Consortium, Kaminsky, E.B., Sanders, S.J., GeneSTAR, Myers, S.M., et al., 2010. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. American Journal of Human Genetics 87, 618-630.
77. Morrow, E.M., Yoo, S.Y., Flavell, S.W., Kim, T.K., Lin, Y., Hill, R.S., Mukaddes, N.M., Balkhy, S., Gascon, G., Hashimi, A., et al., 2008. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218-223.
78. Mundo, E., Tharmalingham, S., Neves-Pereira, M., Dalton, E.J., Macciardi, F., Parikh, S.V., Bolonna, A., Kerwin, R.W., Arranz, M.J., Makoff, A.J., Kennedy, J.L., 2003. Evidence that the N-methyl-d-aspartate subunits 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Molecular Psychiatry 8, 241-245.
79. Nicholas, B., Rudrasingham, V., Nash, S., Kirov, G., Owen, M.J., Wimpory, D.C., 2007. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Molecular Psychiatry 12, 581-592.
80. Nyegaard, M., Demontis, D., Foldager, L., Hedemand, A., Flint, T.J., Sorensen, K.M., Andersen, P.S., Nordentoft, M., Werge, T., Pedersen, C.B., et al., 2010. CACNA1C (rs1006737) is associated with schizophrenia. Molecular Psychiatry 15, 119-121.
81. Pasca, S.P., Portmann, T., Vioneagu, I., Yazawa, M., Shcheglovitov, A., Pasca, A.M., Cord, B., Palmer, R.D., Chikahisa, S., Nishino, S., et al., 2011. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Medicine 17, 1657-1662.
82. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B., Karandikar, M., Berman, K., Cobb, M.H., 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22, 153-183.
83. Perkinton, M.S., Ip, J.K., Wood, G.L., Crossthwaite, A.J., Williams, R.J., 2002. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. Journal of Neurochemistry 80, 239-254.
84. Pinto, D., Pagnamenta, A.T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magelhaes, T.R., Correia, C., Abrahams, B.S., et al., 2010. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368-372.
85. Polleux, F., Lauder, J.M., 2004. Toward a developmental neurobiology of autism. Mental Retardation and Developmental Disabilities Research Reviews 10, 303-317.
86. Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J.A., Steckler, T., 2006. Transgenic mice overexpressing glycogen synthase kinase 3β: a putative model of hyperactivity and mania. Journal of Neuroscience 26, 9022-9029.
87. Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., Pevsner, J., 2001. Postmortem abnormalities of the glutamate neurotransmitter system in autism. Neurology 57, 1618-1628.
88. Qin, Y., Zhu, Y., Baumgart, J.P., Stornetta, R.L., Seidenman, K., Mack, V., van Aelst, L., Zhu, J.J., 2005. State-dependent Ras signaling and AMPA receptor trafficking. Genes & Development 19, 2000-2015.
89. Reichenbach, H., Meister, E.M., Theile, H., 1992. The heart-hand syndrome. A new variant of disorders of heart condition and syndactylia including osseous changes in hand and feet. Kinderarztliche Praxis 60, 54-56.
90. Reynolds, A.M., Malow, B.A., 2011. Sleep and autism spectrum disorders. Pediatric Clinics of North America 58, 658-698.
91. Rinaldi, T., Kulangara, K., Antoniello, K., Markram, H., 2007. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proceedings of the National Academy of Sciences of the United States of America 104, 13501-13506.
92. Roberts, A.E., Araki, T., Swanson, K.D., Montgomery, K.T., Schiripo, T.A., Joshi, V.A., Li, L., Yassin, Y., Tamburino, A.M., Neel, B.G., Kucherlapati, R.S., 2007. Germline gain-of-function mutation in SOS1 cause Noonan syndrome. Nature Genetics 39, 70-75.
93. Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M.J., Waterfield, M.D., Downward, J., 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
94. Rose, J., Jin, S.X., Craig, A.M., 2009. Heterosynaptic molecular dynamics: locally induced propagating synaptic accumulation of CaM kinase II. Neuron 61, 351-358.
95. Rosenberg, R.E., Law, J.K., Yenokyan, G., McGready, J., Kaufmann, W.E., Law, P.A., 2009. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Archives of Pediatrics and Adolescent Medicine 163, 907-914.
96. Rubio, I., Wetzker, R., 2000. A permissive function of phosphoinositide 3-kinase in Ras activation mediated by nhibition of GTPase-activating proteins. Current Biology 10, 1225-1228.
97. Rumbaugh, G., Adams, J.P., Kim, J.H., Huganir, R.L., 2006. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proceedings of the National Academy of Sciences of the United States of America 103, 4344-4351.
98. Sakai, Y., Shaw, C.A., Dawson, B.C., Dugas, D.V., Al-Mohtaseb, Z., Hill, D.E., Zoghbi, H.Y., 2011. Protein interactome reveals converging molecular pathways among autism disorders. Science Translational Medicine 3, 86ra49.
99. Satoh, Y., Endo, S., Ikeda, T., Yamada, K., Ito, M., Kuroki, M., Hiramoto, T., Imamura, O., Kobayashi, Y., Watanabe, Y., et al., 2007. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. Journal of Neuroscience 27, 10765-10776.
100. v1.3 channels. Journal of Neuroscience 31, 13562-13575.
101. Schneider, A., Gartenhaus, R.B., 2010. AMPK signaling; a targetable tumor suppressor pathway? Cancer Biology and Therapy 10, 1178-1181.
102. Shinawi, M., Liu, P., Kang, S.H.L., Shen, J., Belmont, J.W., Scott, D.A., Probst, F.J., Craigen, W.J., Graham, B.H., Pursley, A., et al., 2010. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphisms, epilepsy, and abnormal head size. Journal of Medical Genetics 47, 332-341.
103. Sklar, P., Smoller, J.W., Fan, J., Ferreira, M.A., Perlis, R.H., Chambert, K., Nimgoankar, V.L., McQueen, M.B., Faraone, S.V., Kirby, A., et al., 2008. Whole-genome association study of bipolar disorder. Molecular Psychiatry 13, 558-569.
104. Sklar, P., Ripke, S., Scott, L.J., Andreassen, O.A., Cichon, S., Craddock, N., Edenberg, H.J., Nurnberger, J.I., Rietschell, M., Blackwood, D., et al., 2011. Large-scale genomewide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 43, 977-983.
105. v1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31.
106. Thomas, G.M., Huganir, R.L., 2004. MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience 5, 173-183.
107. Thorson, J.A., Yu, L.W.K., Hsu, A.L., Shih, N.Y., Graves, P.R., Tanner, J.W., Allen, P.M., Piwnica-Worms, H., Shaw, A.S., 1998. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Molecular and Cellular Biology 18, 5229-5238.
108. Tian, X., Gotoh, T., Tsuji, K., Lo, E.H., Huang, S., Feig, L.A., 2004. Developmentally regulated role for Ras-GRFs in coupling to NMDA glutamate receptors to Ras, Erk and CREB. The EMBO Journal 23, 1567-1575.
109. Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., Bourgeron, T., 2010. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in Genetics 26, 363-372.
110. Triggle, D.J., 2006. L-type calcium channels. Current Pharmaceutical Design 12, 443-457.
111. Vantaggiato, C., Formentini, I., Bondanza, A., Bonini, C., Naldini, L., Brambilla, R., 2006. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell differentiation. Journal of Biology 5, 14.
112. Volkmar, F.R., State, M., Klin, A., 2009. Autism and autism spectrum disorders: diagnostic issues for the coming decade. Journal of Child Psychology and Psychiatry and Allied Disciplines 50, 108-115.
113. Wayman, G.A., Impey, S., Marks, D., Saeyoshi, T., Grant, W.F., Derkach, V., Söderling, T.R., 2006. Activity dependent dendritic arborization mediated by CaM-kinase 1 activation and enhanced CREB-dependent transcription of Wnt2. Neuron 50, 897-909.
114. Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A.R., Green, T., et al., 2008. Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine 358, 667-675.
115. Williams, P.G., Hersh, J.H., 1998. Brief report: the association of neurofibromatosis type 1 and autism. Journal of Autism and Developmental Disorders 28, 567-571.
116. Yuan, P.X., Huang, L.D., Jiang, Y.M., Gutkind, J.S., Manji, H.K., Chen, G., 2001. The mood stabilizer valproic acid activates mitogen-activated protein kinase and promotes neurite outgrowth. Journal of Biological Chemistry 276, 31674-31683.
117. Zhang, Y.Y., Wu, J.W., Wang, Z.X., 2011. Mitogen-activated protein kinase (MAPK) phosphatase 2-mediated cross-talk between MAPKs ERK2 and p38alpha. Journal of Biological Chemistry 628, 16150-16162.
118. Zhao, Q., Che, R., Zhang, Z., Wang, P., Li, J., Li, Y., Huang, K., Tang, W., Feng, G., Lindpainter, K., et al., 2011. Positive association between GRIN2B gene and bipolar disorder in the Chinese Han population. Psychiatry Research 185, 290-292.